PEN 203Alternative Names: Papirine
Latest Information Update: 29 May 2007
At a glance
- Originator Cambrex Corporation; CoPharma
- Developer CoPharma
- Class Antivirals
- Mechanism of Action Immunostimulants; Ribonuclease stimulants; Virus replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Herpesvirus infections; Human papillomavirus infections